Min Suk Lee

7765393, Jul 27, 2010

Jul 11, 2006

11/484979

Min Eig Lee - Palo Alto CA, US
Chih-Yi Chen - San Jose CA, US
Huynh Duc Mai - Milpitas CA, US
Pradeep Kalra - San Jose CA, US

Network Appliance, Inc. - Sunnyvale CA

G06F 9/00

713 2, 714 6

An IBM PC compatible processing system typically has a BIOS installed as system firmware. During a boot process of the processing system, the BIOS loads a boot loader from one of the boot media, i. e. , hard drives, floppy disks, CDs, USB flash memories, taps, etc. and passes control of the boot loader, the boot loader then loads an OS from the boot media. The present invention takes advantage of the higher reliability and availability provided by the system flash memory and stores a boot loader as system firmware in the system flash memory. Further, it provides changes in the BIOS boot process to load the boot loader from system memory, the ROM, for example, without relying on boot media. With this new process, the boot loader can be loaded even when the boot media is corrupt, defective or un-initialized.

7964534, Jun 21, 2011

Mar 12, 2004

10/799934

Mark Kelly - San Francisco CA, US
Hugo Villar - San Diego CA, US
Jianqiang Wang - Acton MA, US
Min S. Lee - Madison WI, US
Yong Qin - Chengdu, CN
Daniel S. Sem - New Berlin WI, US

Triad Liquidating Company, LLC - Rancho Santa Fe CA

C40B 20/04
C40B 20/08
C40B 30/04
C40B 30/10
G01N 33/53
G01N 33/48
G06G 7/58

506 4, 506 6, 506 9, 506 12, 435 71

The invention provides a method for identifying a ligand that binds to a macromolecular target. The methods involve (a) attaching an antenna moiety to a first ligand, wherein the ligand binds specifically to a macromolecular target; (b) providing a sample comprising the macromolecular target, the first ligand and a candidate second ligand under conditions wherein the first ligand and the macromolecular target form a bound complex; (c) detecting a subset of magnetization transfer signals between the antenna moiety of the first ligand and the second candidate ligand, wherein the signals are obtained from an isotope edited NOESY spectrum of the sample; thereby determining that the two ligands are proximal in a bound complex, and identifying a second ligand that binds to the macromolecular target.

20040102476, May 27, 2004

Nov 25, 2002

10/305252

Tai Chan - Palo Alto CA, US
Wilma Tamraz - San Jose CA, US
Min Lee - Saratoga CA, US

A61K031/445
A61K031/19

514/317000, 514/557000

The present invention provides opioid formulations suitable for long-term delivery to a subject. The formulation of the invention comprises an opioid or opioid derivative (e.g., morphine, hydromorphone, fentanyl or a fentanyl congener), and an aqueous solvent comprising a low molecular weight carboxylic acid (e.g., C, C). The invention thus provides for formulations comprising morphine, hydromorphone, fentanyl or fentanyl congeners in concentrations significantly in excess of conventional aqueous formulations, e.g., on the order about 2-fold to about 10,000-fold greater than conventional formulations, e.g., currently commercially available formulations.

20110136847, Jun 9, 2011

Sep 17, 2010

12/885345

Tai Wah Chan - Palo Alto CA, US
Wilma Tamraz - San Jose CA, US
Min Lee - Saratoga CA, US

A61K 31/46
A61K 31/4535
A61K 31/445
A61P 29/00

514282, 514326, 514329

The present invention provides opioid formulations suitable for long-term delivery to a subject. The formulation of the invention comprises an opioid or opioid derivative (e.g., morphine, hydromorphone, fentanyl or a fentanyl congener), and an aqueous solvent comprising a low molecular weight carboxylic acid (e.g., C, C). The invention thus provides for formulations comprising morphine, hydromorphone, fentanyl or fentanyl congeners in concentrations significantly in excess of conventional aqueous formulations, e.g., on the order about 2-fold to about 10,000-fold greater than conventional formulations, e.g., currently commercially available formulations.

20220175798, Jun 9, 2022

Nov 15, 2021

17/526493

- Cupertino CA, US
WeiQi Lin - Emerald Hills CA, US
Mee Jean Kim - San Francisco CA, US
Hongwei Wu - Cupertino CA, US
Min L. Lee - Saratoga CA, US
Wendy Chao - San Jose CA, US

A61K 31/575
A61P 1/16
A61K 47/10

Compositions comprising oxygenated cholesterol sulfates (OCS) are provided. The OCS is, for example, 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or 5-cholesten, 3, 25-diol, disulfate (25HCDS). The compositions may be used to prevent and/or treat a variety of diseases and conditions, including organ failure (e.g. acute liver failure due to acetaminophen), high cholesterol/high lipids, and various inflammatory diseases and conditions.

20200222430, Jul 16, 2020

Aug 1, 2017

16/320074

- Cupertino CA, US
WeiQi Lin - Emerald Hills CA, US
Mee Jean Kim - San Francisco CA, US
Hongwei Wu - Cupertino CA, US
Min L. Lee - Saratoga CA, US
Wendy Chao - San Jose CA, US

A61K 31/575
A61K 47/10
A61P 1/16

Compositions comprising oxygenated cholesterol sulfates (OCS) are provided. The OCS is, for example, 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or 5-cholesten, 3, 25-diol, disulfate (25HCDS). The compositions may be used to prevent and/or treat a variety of diseases and conditions, including organ failure (e.g. acute liver failure due to acetaminophen), high cholesterol/high lipids, and various inflammatory diseases and conditions.

20200080856, Mar 12, 2020

Oct 10, 2019

16/599086

- San Francisco CA, US
Christopher Blumenberg - San Francsico CA, US
Billy Chen - San Francisco CA, US
Rohan Paranjpe - San Francisco CA, US
Christopher Moore - San Francisco CA, US
Min Ji Lee - San Francisco CA, US
Erik Reed - San Francisco CA, US

G01C 21/34
G06Q 30/02
G06Q 50/30
G06Q 10/06
G06Q 10/04

A method includes storing representations of a passengers and fleet vehicles. The method includes generating a graph representation of a geographic map that includes requested pick-up locations and drop-off locations for the passengers and generating a state graph representation of the passengers and the fleet vehicles. The state graph representation includes a plurality of nodes connected by edges. Each of the plurality of nodes represents a candidate state of the passengers and the fleet vehicles. A respective edge of the state graph representation represents an action of a respective vehicle picking up or dropping off a passenger. The respective edge has a cost that is based at least in part on traversal of the graph representation of the geographic map. The method further includes using the state graph representation to generate a set of routes and route the fleet vehicles in accordance with the generated set of routes.

20190374554, Dec 12, 2019

Aug 1, 2017

16/320400

- Richmond VA, US
- Cupertino CA, US
James E. Brown - Los Gatos CA, US
Felix Theeuwes - Los Altos Hills CA, US
Mee Jean Kim - San Francisco CA, US
Andrew R. Miksztal - Palo Alto CA, US
Hongwei Wu - Cupertino CA, US
Min L. Lee - Saratoga CA, US
Huey-Ching Su - San Jose CA, US
Wilma Tamraz - San Jose CA, US

A61K 31/575
A61K 47/12
A61K 47/10
A61K 47/14
A61K 9/06
A61P 17/06

Methods of treating and prophylactically treating inflammatory skin diseases and skin lesions are provided. For instance, the methods may involve contacting the skin with an oxygenated cholesterol sulfate (OCS), e.g. 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or a pharmaceutically acceptable salt thereof.